Sharon Fried, MD
Procedural Dermatology · Englewood, NJNPI 1740236975
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $123 of the $158 with a category attached, or 77.9%. 6 manufacturers reported payments, led by Dermavant Sciences, Inc. at 25.3% of the total. That places this record below the midpoint for procedural dermatology clinicians in NJ, where the typical reported total is $1,506.
Across 8 payments — averaging $19.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dermavant Sciences, Inc.$40
- Regeneron Healthcare Solutions, Inc.$38
- Pfizer$35
- Almirall LLC$18
- Convatec Inc.$14
- Organon$13
What the payments were for
- Food & beverage$12378%
- Education$3522%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dermavant Sciences, Inc. | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Pfizer | 1 | $35 |
| Almirall LLC | 1 | $18 |
| Convatec Inc. | 1 | $14 |
| Organon | 1 | $13 |
How this compares
$158 in reported general payments places this provider in the 25th percentile of 22 procedural dermatology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 12 | $81,657 |
| Metronidazole | 25 | $2,004 |
| Mometasone Furoate | 102 | $1,701 |
| Clindamycin Phosphate | 48 | $1,589 |
| Ketoconazole | 91 | $1,469 |
| Betamethasone Dipropionate | 25 | $1,333 |
| Fluorouracil | 11 | $674 |
| Doxycycline Hyclate | 16 | $479 |
| Gentamicin Sulfate | 23 | $442 |
| Mupirocin | 65 | $433 |
| Triamcinolone Acetonide | 29 | $417 |
| Clobetasol Propionate | 14 | $312 |
| Imiquimod | 16 | $249 |
| Fluocinonide | 15 | $246 |
| Hydrocortisone | 54 | $211 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Englewood
- Gwen AbelesMontvale$9K
- Kenneth GrossmanLittle Silver$9K
- Margarita LolisHackensack$9K
- Cheryl CitronLivingston$5K
- Dawn GangiMendham$5K
- David KikenFlorham Park$5K
- Marc HandlerHamilton$4K
- Jeffrey RapaportEnglewood Cliffs$3K
- Michael BilkisVerona$2K
- Naana BoakyeEnglewood Cliffs$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.